

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.22888255 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.22888255 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.90055031 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.90055031 |
| 5 | postsynaptic membrane organization (GO:0001941) | 4.84976422 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 4.59086824 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.36956019 |
| 8 | central nervous system myelination (GO:0022010) | 4.27747656 |
| 9 | axon ensheathment in central nervous system (GO:0032291) | 4.27747656 |
| 10 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.18954509 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 4.17530381 |
| 12 | glutamate metabolic process (GO:0006536) | 4.12943218 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.12866238 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.07912352 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.05754352 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.05264921 |
| 17 | presynaptic membrane assembly (GO:0097105) | 4.03863025 |
| 18 | gamma-aminobutyric acid transport (GO:0015812) | 4.02649413 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 4.01867536 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 4.01867536 |
| 21 | tryptophan catabolic process (GO:0006569) | 4.01867536 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 4.01610089 |
| 23 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.91260425 |
| 24 | glyoxylate metabolic process (GO:0046487) | 3.90940654 |
| 25 | L-amino acid import (GO:0043092) | 3.87778154 |
| 26 | presynaptic membrane organization (GO:0097090) | 3.86145466 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.85009445 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.82926684 |
| 29 | sodium ion export (GO:0071436) | 3.79297217 |
| 30 | tryptophan metabolic process (GO:0006568) | 3.74454031 |
| 31 | lysine metabolic process (GO:0006553) | 3.74433175 |
| 32 | lysine catabolic process (GO:0006554) | 3.74433175 |
| 33 | cysteine metabolic process (GO:0006534) | 3.74135237 |
| 34 | urea cycle (GO:0000050) | 3.69688703 |
| 35 | urea metabolic process (GO:0019627) | 3.69688703 |
| 36 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.60240620 |
| 37 | cerebellar granule cell differentiation (GO:0021707) | 3.59621375 |
| 38 | exploration behavior (GO:0035640) | 3.58425095 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 3.58128645 |
| 40 | locomotory exploration behavior (GO:0035641) | 3.57988896 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 3.57581781 |
| 42 | nucleobase catabolic process (GO:0046113) | 3.55967032 |
| 43 | synaptic vesicle maturation (GO:0016188) | 3.55719801 |
| 44 | neuronal action potential propagation (GO:0019227) | 3.55383306 |
| 45 | amino acid import (GO:0043090) | 3.53681574 |
| 46 | sulfur amino acid catabolic process (GO:0000098) | 3.51555923 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.49173150 |
| 48 | bile acid metabolic process (GO:0008206) | 3.44313584 |
| 49 | drug catabolic process (GO:0042737) | 3.44186452 |
| 50 | auditory behavior (GO:0031223) | 3.42425791 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 3.39608177 |
| 52 | protein localization to synapse (GO:0035418) | 3.39567736 |
| 53 | regulation of synapse structural plasticity (GO:0051823) | 3.39260600 |
| 54 | dicarboxylic acid catabolic process (GO:0043649) | 3.36011120 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 3.35789150 |
| 56 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.35576388 |
| 57 | synaptic transmission, glutamatergic (GO:0035249) | 3.34986573 |
| 58 | potassium ion import (GO:0010107) | 3.31934211 |
| 59 | serine family amino acid catabolic process (GO:0009071) | 3.31907638 |
| 60 | negative regulation of fibrinolysis (GO:0051918) | 3.31593964 |
| 61 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.31214675 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 3.30128333 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 3.27089501 |
| 64 | * neurotransmitter secretion (GO:0007269) | 3.25986376 |
| 65 | homocysteine metabolic process (GO:0050667) | 3.25200994 |
| 66 | reverse cholesterol transport (GO:0043691) | 3.24922145 |
| 67 | cellular sodium ion homeostasis (GO:0006883) | 3.24704345 |
| 68 | epoxygenase P450 pathway (GO:0019373) | 3.24459663 |
| 69 | response to auditory stimulus (GO:0010996) | 3.24013998 |
| 70 | vocalization behavior (GO:0071625) | 3.20056551 |
| 71 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.19686202 |
| 72 | omega-hydroxylase P450 pathway (GO:0097267) | 3.19022383 |
| 73 | regulation of fibrinolysis (GO:0051917) | 3.17083042 |
| 74 | regulation of cholesterol esterification (GO:0010872) | 3.16068483 |
| 75 | aspartate family amino acid catabolic process (GO:0009068) | 3.15526177 |
| 76 | * cellular amino acid catabolic process (GO:0009063) | 3.15412505 |
| 77 | potassium ion homeostasis (GO:0055075) | 3.15376864 |
| 78 | regulation of protein activation cascade (GO:2000257) | 3.14379581 |
| 79 | exogenous drug catabolic process (GO:0042738) | 3.14305824 |
| 80 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.13558843 |
| 81 | protein carboxylation (GO:0018214) | 3.13558843 |
| 82 | complement activation, alternative pathway (GO:0006957) | 3.13294183 |
| 83 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.13080092 |
| 84 | tyrosine metabolic process (GO:0006570) | 3.12935830 |
| 85 | axonal fasciculation (GO:0007413) | 3.12199149 |
| 86 | transmission of nerve impulse (GO:0019226) | 3.12001152 |
| 87 | protein-lipid complex remodeling (GO:0034368) | 3.11557587 |
| 88 | macromolecular complex remodeling (GO:0034367) | 3.11557587 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 3.11557587 |
| 90 | glutamate secretion (GO:0014047) | 3.11471273 |
| 91 | ketone body metabolic process (GO:1902224) | 3.09451439 |
| 92 | coenzyme catabolic process (GO:0009109) | 3.09201728 |
| 93 | short-chain fatty acid metabolic process (GO:0046459) | 3.07799064 |
| 94 | glutamate receptor signaling pathway (GO:0007215) | 3.07432374 |
| 95 | amino-acid betaine metabolic process (GO:0006577) | 3.07233972 |
| 96 | C4-dicarboxylate transport (GO:0015740) | 3.05440751 |
| 97 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.04745982 |
| 98 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.01531096 |
| 99 | negative regulation of sterol transport (GO:0032372) | 3.00020533 |
| 100 | negative regulation of cholesterol transport (GO:0032375) | 3.00020533 |
| 101 | neuron recognition (GO:0008038) | 2.99876577 |
| 102 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.99393889 |
| 103 | indolalkylamine metabolic process (GO:0006586) | 2.96140429 |
| 104 | neuron-neuron synaptic transmission (GO:0007270) | 2.95493469 |
| 105 | synaptic vesicle exocytosis (GO:0016079) | 2.95075390 |
| 106 | regulation of complement activation (GO:0030449) | 2.91449584 |
| 107 | neurotransmitter uptake (GO:0001504) | 2.89957091 |
| 108 | positive regulation of synapse maturation (GO:0090129) | 2.88839498 |
| 109 | acylglycerol homeostasis (GO:0055090) | 2.86509879 |
| 110 | triglyceride homeostasis (GO:0070328) | 2.86509879 |
| 111 | neuronal ion channel clustering (GO:0045161) | 2.86100560 |
| 112 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.86054874 |
| 113 | layer formation in cerebral cortex (GO:0021819) | 2.85698132 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 2.84581191 |
| 115 | drug transmembrane transport (GO:0006855) | 2.83631636 |
| 116 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.83623010 |
| 117 | positive regulation of membrane potential (GO:0045838) | 2.82441332 |
| 118 | neuromuscular process controlling posture (GO:0050884) | 2.82205351 |
| 119 | regulation of triglyceride catabolic process (GO:0010896) | 2.82133562 |
| 120 | synaptic vesicle endocytosis (GO:0048488) | 2.81263825 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 2.80716011 |
| 122 | mechanosensory behavior (GO:0007638) | 2.79741867 |
| 123 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.78359179 |
| 124 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.76971696 |
| 125 | positive regulation of dendritic spine development (GO:0060999) | 2.76682420 |
| 126 | glutamine family amino acid catabolic process (GO:0009065) | 2.76432681 |
| 127 | phospholipid efflux (GO:0033700) | 2.75746929 |
| 128 | bile acid and bile salt transport (GO:0015721) | 2.75707564 |
| 129 | glycine transport (GO:0015816) | 2.74555074 |
| 130 | cholesterol efflux (GO:0033344) | 2.74368619 |
| 131 | cell communication by electrical coupling (GO:0010644) | 2.73636278 |
| 132 | benzene-containing compound metabolic process (GO:0042537) | 2.72792612 |
| 133 | acidic amino acid transport (GO:0015800) | 2.72605766 |
| 134 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71562034 |
| 135 | 2-oxoglutarate metabolic process (GO:0006103) | 2.71435667 |
| 136 | regulation of neurotransmitter secretion (GO:0046928) | 2.71150713 |
| 137 | arginine metabolic process (GO:0006525) | 2.70807855 |
| 138 | succinate metabolic process (GO:0006105) | 2.70345058 |
| 139 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.69771070 |
| 140 | indole-containing compound metabolic process (GO:0042430) | 2.69383271 |
| 141 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.69223928 |
| 142 | establishment of mitochondrion localization (GO:0051654) | 2.67862228 |
| 143 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.67711814 |
| 144 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.67675927 |
| 145 | dendrite morphogenesis (GO:0048813) | 2.66963516 |
| 146 | cellular glucuronidation (GO:0052695) | 2.66188130 |
| 147 | ethanol oxidation (GO:0006069) | 2.65217631 |
| 148 | * neurotransmitter transport (GO:0006836) | 2.64846790 |
| 149 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.63176454 |
| 150 | * regulation of neurotransmitter levels (GO:0001505) | 2.62219353 |
| 151 | regulation of synaptic vesicle transport (GO:1902803) | 2.61562375 |
| 152 | * organic acid catabolic process (GO:0016054) | 2.61238367 |
| 153 | * carboxylic acid catabolic process (GO:0046395) | 2.61238367 |
| 154 | alanine transport (GO:0032328) | 2.61190339 |
| 155 | cellular biogenic amine catabolic process (GO:0042402) | 2.60973045 |
| 156 | amine catabolic process (GO:0009310) | 2.60973045 |
| 157 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.60906557 |
| 158 | regulation of neurotransmitter transport (GO:0051588) | 2.60447593 |
| 159 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.59477780 |
| 160 | long-term memory (GO:0007616) | 2.58967177 |
| 161 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.56470239 |
| 162 | neuromuscular process controlling balance (GO:0050885) | 2.53962645 |
| 163 | regulation of postsynaptic membrane potential (GO:0060078) | 2.52365726 |
| 164 | adult walking behavior (GO:0007628) | 2.48943353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.47654432 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.89454249 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.42708867 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15412099 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.10426252 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.70781964 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.45074633 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.36359215 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32546296 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32178274 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.22189052 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04420019 |
| 13 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.03791156 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00021119 |
| 15 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.99572791 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.99443300 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97299478 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.94639339 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.94639339 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.93915432 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.90812712 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.89428520 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.84740835 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81499623 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80858944 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80059903 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.79943941 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78624079 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69179025 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66237534 |
| 31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66079615 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65846142 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64609600 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.60345295 |
| 35 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.57981704 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52838472 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50971409 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48213743 |
| 39 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47950997 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.43213968 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.41382126 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.39770388 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38847676 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35642416 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32062605 |
| 46 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28711807 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26481102 |
| 48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22654279 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22153723 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21118726 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20640855 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19335864 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18831834 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18066513 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17792371 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13804427 |
| 57 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12300045 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11708186 |
| 59 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11060268 |
| 60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10098967 |
| 61 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10091351 |
| 62 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09534431 |
| 63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09336401 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08395223 |
| 65 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06955126 |
| 66 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06955126 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06657681 |
| 68 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06523201 |
| 69 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05912376 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05244768 |
| 71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04945970 |
| 72 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04777118 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03952850 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03130571 |
| 75 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02941051 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.01643704 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00727392 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00414191 |
| 79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00383138 |
| 80 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99565087 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98841556 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97525106 |
| 83 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95895665 |
| 84 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95445945 |
| 85 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95384801 |
| 86 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95213665 |
| 87 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94587793 |
| 88 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94363119 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93785863 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.93380979 |
| 91 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92823887 |
| 92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92443843 |
| 93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92268640 |
| 94 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92230073 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92222048 |
| 96 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90285120 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90059419 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87524494 |
| 99 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87014654 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86796015 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86077099 |
| 102 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84967821 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84295315 |
| 104 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83052911 |
| 105 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.82900136 |
| 106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82508995 |
| 107 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81630139 |
| 108 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.81435099 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81187032 |
| 110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81113924 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80527804 |
| 112 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80019903 |
| 113 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79862097 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78949830 |
| 115 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78347680 |
| 116 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77665323 |
| 117 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76276990 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76078791 |
| 119 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.75922375 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.75461430 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75420446 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75420446 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.74143065 |
| 124 | TCF4_23295773_ChIP-Seq_U87_Human | 0.73444399 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.73101009 |
| 126 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.72322449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.55278629 |
| 2 | MP0005360_urolithiasis | 5.27087082 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.28757477 |
| 4 | MP0005365_abnormal_bile_salt | 3.95783179 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.86008587 |
| 6 | MP0002822_catalepsy | 3.61040688 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.46539270 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.62866019 |
| 9 | MP0003252_abnormal_bile_duct | 2.57850273 |
| 10 | MP0003122_maternal_imprinting | 2.48696552 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.47980329 |
| 12 | MP0003880_abnormal_central_pattern | 2.43102205 |
| 13 | MP0009745_abnormal_behavioral_response | 2.31927383 |
| 14 | MP0003195_calcinosis | 2.29165366 |
| 15 | MP0005332_abnormal_amino_acid | 2.22470207 |
| 16 | MP0002064_seizures | 2.17759463 |
| 17 | MP0009046_muscle_twitch | 2.14282272 |
| 18 | MP0004270_analgesia | 2.11658668 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.08716405 |
| 20 | MP0003329_amyloid_beta_deposits | 1.95475175 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.89159874 |
| 22 | MP0005083_abnormal_biliary_tract | 1.88884416 |
| 23 | MP0003136_yellow_coat_color | 1.82183754 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 1.76812526 |
| 25 | MP0005423_abnormal_somatic_nervous | 1.74256652 |
| 26 | MP0003787_abnormal_imprinting | 1.72639891 |
| 27 | MP0001486_abnormal_startle_reflex | 1.70231613 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.69231998 |
| 29 | MP0002272_abnormal_nervous_system | 1.68051113 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.67445734 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.65298394 |
| 32 | MP0009840_abnormal_foam_cell | 1.62866442 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.61826488 |
| 34 | MP0003690_abnormal_glial_cell | 1.60152863 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.59611920 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.56311874 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.55614597 |
| 38 | MP0001968_abnormal_touch/_nociception | 1.54444323 |
| 39 | MP0004043_abnormal_pH_regulation | 1.53218822 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.51128266 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.42966318 |
| 42 | MP0000566_synostosis | 1.39710077 |
| 43 | MP0000604_amyloidosis | 1.37964620 |
| 44 | MP0004885_abnormal_endolymph | 1.36954825 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35639923 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.34752316 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.33193864 |
| 48 | MP0005535_abnormal_body_temperature | 1.28838491 |
| 49 | MP0003868_abnormal_feces_composition | 1.25294288 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.21207041 |
| 51 | MP0003633_abnormal_nervous_system | 1.18965471 |
| 52 | MP0004924_abnormal_behavior | 1.16475167 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.16475167 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.15761448 |
| 55 | MP0002152_abnormal_brain_morphology | 1.13211131 |
| 56 | MP0008569_lethality_at_weaning | 1.13185054 |
| 57 | MP0004742_abnormal_vestibular_system | 1.11670343 |
| 58 | MP0008872_abnormal_physiological_respon | 1.11318089 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.07601364 |
| 60 | MP0000609_abnormal_liver_physiology | 1.07378541 |
| 61 | MP0003121_genomic_imprinting | 1.07005945 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.07004443 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.06231735 |
| 64 | MP0001905_abnormal_dopamine_level | 1.05405791 |
| 65 | MP0002249_abnormal_larynx_morphology | 1.05224008 |
| 66 | MP0004142_abnormal_muscle_tone | 1.04992075 |
| 67 | MP0002736_abnormal_nociception_after | 1.04487650 |
| 68 | MP0006276_abnormal_autonomic_nervous | 1.04244073 |
| 69 | MP0004858_abnormal_nervous_system | 1.04057628 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.03218677 |
| 71 | MP0001970_abnormal_pain_threshold | 1.01709550 |
| 72 | MP0001984_abnormal_olfaction | 1.01698610 |
| 73 | MP0008874_decreased_physiological_sensi | 1.01551993 |
| 74 | MP0001963_abnormal_hearing_physiology | 1.01332083 |
| 75 | MP0003879_abnormal_hair_cell | 1.00290962 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.99054063 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.97550972 |
| 78 | MP0003631_nervous_system_phenotype | 0.95378145 |
| 79 | MP0003075_altered_response_to | 0.95266631 |
| 80 | MP0002066_abnormal_motor_capabilities/c | 0.94592495 |
| 81 | MP0003123_paternal_imprinting | 0.94500835 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.92942909 |
| 83 | MP0000026_abnormal_inner_ear | 0.92702471 |
| 84 | MP0004811_abnormal_neuron_physiology | 0.92491595 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 0.89441678 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.88448195 |
| 87 | MP0005187_abnormal_penis_morphology | 0.88091375 |
| 88 | MP0000955_abnormal_spinal_cord | 0.87883652 |
| 89 | MP0002735_abnormal_chemical_nociception | 0.87704226 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.87525564 |
| 91 | MP0001502_abnormal_circadian_rhythm | 0.86930058 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.85695306 |
| 93 | MP0001177_atelectasis | 0.85580738 |
| 94 | MP0004130_abnormal_muscle_cell | 0.83150815 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.81846431 |
| 96 | MP0005645_abnormal_hypothalamus_physiol | 0.81745498 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.81296674 |
| 98 | MP0001764_abnormal_homeostasis | 0.79298917 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.78916365 |
| 100 | MP0004133_heterotaxia | 0.78193963 |
| 101 | MP0002229_neurodegeneration | 0.77400243 |
| 102 | MP0002752_abnormal_somatic_nervous | 0.77266078 |
| 103 | MP0002090_abnormal_vision | 0.76648343 |
| 104 | MP0001529_abnormal_vocalization | 0.75212755 |
| 105 | MP0003632_abnormal_nervous_system | 0.74155962 |
| 106 | MP0000920_abnormal_myelination | 0.73737461 |
| 107 | MP0003283_abnormal_digestive_organ | 0.73647929 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 0.73508374 |
| 109 | MP0002184_abnormal_innervation | 0.73480446 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.72484676 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.72453087 |
| 112 | MP0005448_abnormal_energy_balance | 0.71910187 |
| 113 | MP0005248_abnormal_Harderian_gland | 0.71811392 |
| 114 | MP0002882_abnormal_neuron_morphology | 0.68647904 |
| 115 | MP0003953_abnormal_hormone_level | 0.68370507 |
| 116 | MP0000778_abnormal_nervous_system | 0.68205686 |
| 117 | MP0003861_abnormal_nervous_system | 0.67794270 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 0.66737779 |
| 119 | MP0005409_darkened_coat_color | 0.66275075 |
| 120 | MP0001756_abnormal_urination | 0.65221403 |
| 121 | MP0001986_abnormal_taste_sensitivity | 0.64315827 |
| 122 | MP0003938_abnormal_ear_development | 0.62211594 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.61946128 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.60619858 |
| 125 | MP0005253_abnormal_eye_physiology | 0.60290095 |
| 126 | MP0003634_abnormal_glial_cell | 0.58366708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.19668657 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.08199467 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.81747209 |
| 4 | Myokymia (HP:0002411) | 4.37292545 |
| 5 | Xanthomatosis (HP:0000991) | 4.34092034 |
| 6 | Focal motor seizures (HP:0011153) | 4.19758716 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.19356338 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.03765534 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.01787513 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.75923085 |
| 11 | Ketosis (HP:0001946) | 3.63010469 |
| 12 | Complement deficiency (HP:0004431) | 3.45664268 |
| 13 | Hyperglycinemia (HP:0002154) | 3.44790942 |
| 14 | Hyperammonemia (HP:0001987) | 3.33422714 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.28209111 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.18360689 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18360689 |
| 18 | Abnormality of binocular vision (HP:0011514) | 3.18338406 |
| 19 | Diplopia (HP:0000651) | 3.18338406 |
| 20 | Focal seizures (HP:0007359) | 3.17971261 |
| 21 | Limb dystonia (HP:0002451) | 3.16696942 |
| 22 | Polyphagia (HP:0002591) | 3.15862256 |
| 23 | Gout (HP:0001997) | 3.15749284 |
| 24 | Hyperglycinuria (HP:0003108) | 3.14787750 |
| 25 | Epidermoid cyst (HP:0200040) | 3.14419009 |
| 26 | Status epilepticus (HP:0002133) | 3.12801350 |
| 27 | Ketoacidosis (HP:0001993) | 3.12299675 |
| 28 | Hemiparesis (HP:0001269) | 3.11055383 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.00787978 |
| 30 | Visual hallucinations (HP:0002367) | 2.95178348 |
| 31 | Delayed CNS myelination (HP:0002188) | 2.92137807 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.84799689 |
| 33 | Abnormality of the corticospinal tract (HP:0002492) | 2.84527087 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.82947703 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.78532778 |
| 36 | Action tremor (HP:0002345) | 2.72253546 |
| 37 | Epileptiform EEG discharges (HP:0011182) | 2.70567236 |
| 38 | Torticollis (HP:0000473) | 2.69895939 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 2.67083103 |
| 40 | Joint hemorrhage (HP:0005261) | 2.65981946 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.65607233 |
| 42 | Hyperventilation (HP:0002883) | 2.65297542 |
| 43 | Hypoglycemic coma (HP:0001325) | 2.64638540 |
| 44 | Generalized tonic-clonic seizures (HP:0002069) | 2.64189514 |
| 45 | Megalencephaly (HP:0001355) | 2.59837573 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 2.59098998 |
| 47 | Fat malabsorption (HP:0002630) | 2.55606654 |
| 48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54328288 |
| 49 | Focal dystonia (HP:0004373) | 2.52639976 |
| 50 | Craniofacial dystonia (HP:0012179) | 2.49175751 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 2.47824291 |
| 52 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.46484120 |
| 53 | Absence seizures (HP:0002121) | 2.46427177 |
| 54 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.45442825 |
| 55 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.45442825 |
| 56 | Impaired social interactions (HP:0000735) | 2.44313423 |
| 57 | Abnormal social behavior (HP:0012433) | 2.44313423 |
| 58 | Postural instability (HP:0002172) | 2.42647149 |
| 59 | Tetraplegia (HP:0002445) | 2.39359936 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.39265549 |
| 61 | Neonatal onset (HP:0003623) | 2.38430840 |
| 62 | Dysdiadochokinesis (HP:0002075) | 2.38183775 |
| 63 | Anxiety (HP:0000739) | 2.37657425 |
| 64 | Intention tremor (HP:0002080) | 2.37633324 |
| 65 | Abnormality of the lower motor neuron (HP:0002366) | 2.36482766 |
| 66 | Sensorimotor neuropathy (HP:0007141) | 2.35608491 |
| 67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.31609476 |
| 68 | Hyperbilirubinemia (HP:0002904) | 2.31419291 |
| 69 | Truncal ataxia (HP:0002078) | 2.30077689 |
| 70 | Alkalosis (HP:0001948) | 2.28078482 |
| 71 | Split foot (HP:0001839) | 2.26955480 |
| 72 | Abnormal eating behavior (HP:0100738) | 2.26587875 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.25925958 |
| 74 | Progressive cerebellar ataxia (HP:0002073) | 2.25563092 |
| 75 | Sleep apnea (HP:0010535) | 2.25497111 |
| 76 | Atonic seizures (HP:0010819) | 2.24495983 |
| 77 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.24311181 |
| 78 | Hypercholesterolemia (HP:0003124) | 2.23999433 |
| 79 | Supranuclear gaze palsy (HP:0000605) | 2.22510553 |
| 80 | Abnormality of complement system (HP:0005339) | 2.21094123 |
| 81 | Poor eye contact (HP:0000817) | 2.19166573 |
| 82 | Skin nodule (HP:0200036) | 2.18532268 |
| 83 | Depression (HP:0000716) | 2.18385630 |
| 84 | Dialeptic seizures (HP:0011146) | 2.17500475 |
| 85 | Hypoglycemic seizures (HP:0002173) | 2.15782859 |
| 86 | Urinary urgency (HP:0000012) | 2.15112200 |
| 87 | Drooling (HP:0002307) | 2.15105526 |
| 88 | Epileptic encephalopathy (HP:0200134) | 2.14161975 |
| 89 | Akinesia (HP:0002304) | 2.13768034 |
| 90 | Papilledema (HP:0001085) | 2.13113423 |
| 91 | Genetic anticipation (HP:0003743) | 2.12285124 |
| 92 | Scanning speech (HP:0002168) | 2.12152885 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 2.11422553 |
| 94 | Irritability (HP:0000737) | 2.10986442 |
| 95 | Hemiplegia (HP:0002301) | 2.10308257 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.08864261 |
| 97 | Cholecystitis (HP:0001082) | 2.08864261 |
| 98 | Ankle clonus (HP:0011448) | 2.07845990 |
| 99 | Increased circulating renin level (HP:0000848) | 2.07758822 |
| 100 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06094841 |
| 101 | Bronchomalacia (HP:0002780) | 2.05871484 |
| 102 | Amblyopia (HP:0000646) | 2.05558268 |
| 103 | Abnormality of the diencephalon (HP:0010662) | 2.04955034 |
| 104 | Confusion (HP:0001289) | 2.04751905 |
| 105 | Abnormality of nucleobase metabolism (HP:0010932) | 2.03597874 |
| 106 | Pheochromocytoma (HP:0002666) | 2.03141926 |
| 107 | Dysmetria (HP:0001310) | 2.02638183 |
| 108 | Hepatoblastoma (HP:0002884) | 2.01813273 |
| 109 | Metabolic acidosis (HP:0001942) | 2.01312414 |
| 110 | Mutism (HP:0002300) | 1.99354739 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 1.98566430 |
| 112 | Spontaneous abortion (HP:0005268) | 1.98204334 |
| 113 | Peripheral hypomyelination (HP:0007182) | 1.97628177 |
| 114 | Mitral stenosis (HP:0001718) | 1.96499563 |
| 115 | Glomerulonephritis (HP:0000099) | 1.96491713 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 1.96430447 |
| 117 | Spastic diplegia (HP:0001264) | 1.95966487 |
| 118 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95362279 |
| 119 | Cholelithiasis (HP:0001081) | 1.95206442 |
| 120 | Excessive salivation (HP:0003781) | 1.93407054 |
| 121 | Febrile seizures (HP:0002373) | 1.92843615 |
| 122 | Gaze-evoked nystagmus (HP:0000640) | 1.90502291 |
| 123 | Blue irides (HP:0000635) | 1.89498441 |
| 124 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.89340471 |
| 125 | Agitation (HP:0000713) | 1.88039500 |
| 126 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87610858 |
| 127 | Hypsarrhythmia (HP:0002521) | 1.86799748 |
| 128 | Spastic gait (HP:0002064) | 1.86218781 |
| 129 | Hyperuricemia (HP:0002149) | 1.86213226 |
| 130 | Increased purine levels (HP:0004368) | 1.86213226 |
| 131 | Turricephaly (HP:0000262) | 1.86058338 |
| 132 | Clonus (HP:0002169) | 1.83013848 |
| 133 | Gait imbalance (HP:0002141) | 1.80890647 |
| 134 | Broad-based gait (HP:0002136) | 1.80877155 |
| 135 | Obstructive sleep apnea (HP:0002870) | 1.76573705 |
| 136 | Lower limb muscle weakness (HP:0007340) | 1.76521973 |
| 137 | Absent speech (HP:0001344) | 1.75738120 |
| 138 | Impaired vibratory sensation (HP:0002495) | 1.75160344 |
| 139 | Aplasia of the phalanges of the hand (HP:0009802) | 1.73477443 |
| 140 | Aplasia involving bones of the extremities (HP:0009825) | 1.73477443 |
| 141 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.73477443 |
| 142 | Oligodactyly (hands) (HP:0001180) | 1.73450180 |
| 143 | Arthropathy (HP:0003040) | 1.71443099 |
| 144 | Systemic lupus erythematosus (HP:0002725) | 1.67282075 |
| 145 | Bifid scrotum (HP:0000048) | 1.63581400 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.63320925 |
| 147 | Hypoplasia of the corpus callosum (HP:0002079) | 1.60594717 |
| 148 | Bradykinesia (HP:0002067) | 1.60160233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.05929325 |
| 2 | NTRK3 | 3.65842886 |
| 3 | MAP3K9 | 2.97565171 |
| 4 | MAP3K4 | 2.82428953 |
| 5 | MAP2K4 | 2.58991669 |
| 6 | DAPK2 | 2.51312243 |
| 7 | MARK1 | 2.29240808 |
| 8 | MINK1 | 2.20211183 |
| 9 | NTRK2 | 2.08999348 |
| 10 | NTRK1 | 2.02134398 |
| 11 | MAP2K7 | 2.02025798 |
| 12 | CAMKK1 | 1.99722222 |
| 13 | KSR2 | 1.98294982 |
| 14 | PRKD3 | 1.95024759 |
| 15 | PAK6 | 1.93641307 |
| 16 | BCKDK | 1.79200164 |
| 17 | STK38 | 1.61553286 |
| 18 | PINK1 | 1.60623802 |
| 19 | SGK223 | 1.52360201 |
| 20 | SGK494 | 1.52360201 |
| 21 | WNK3 | 1.34891708 |
| 22 | OXSR1 | 1.34005593 |
| 23 | INSRR | 1.33461308 |
| 24 | MAP3K2 | 1.31925235 |
| 25 | SIK1 | 1.30416944 |
| 26 | SGK2 | 1.30151821 |
| 27 | SGK3 | 1.29828232 |
| 28 | CDK5 | 1.27264425 |
| 29 | PRKCG | 1.23069185 |
| 30 | NEK6 | 1.20772394 |
| 31 | TYRO3 | 1.17763550 |
| 32 | PRKCH | 1.14970873 |
| 33 | DYRK2 | 1.14634026 |
| 34 | LMTK2 | 1.14310186 |
| 35 | WNK4 | 1.13092806 |
| 36 | EPHA3 | 1.12825942 |
| 37 | MAPK15 | 1.09817098 |
| 38 | DYRK1A | 1.09676972 |
| 39 | ERBB4 | 1.08726865 |
| 40 | KSR1 | 1.07096684 |
| 41 | ARAF | 1.05105434 |
| 42 | CAMKK2 | 1.01245536 |
| 43 | MAP3K12 | 1.01173562 |
| 44 | RET | 1.01019768 |
| 45 | FES | 1.00207236 |
| 46 | TRIB3 | 0.98753758 |
| 47 | TNIK | 0.98727051 |
| 48 | FGFR2 | 0.98124317 |
| 49 | PHKG2 | 0.96659299 |
| 50 | PHKG1 | 0.96659299 |
| 51 | MAP3K13 | 0.96524462 |
| 52 | PIK3CA | 0.96493245 |
| 53 | GRK5 | 0.95739144 |
| 54 | TAOK1 | 0.93606005 |
| 55 | RIPK1 | 0.93223011 |
| 56 | PAK3 | 0.92581475 |
| 57 | PKN1 | 0.88822131 |
| 58 | DAPK1 | 0.88469278 |
| 59 | FGFR4 | 0.87225934 |
| 60 | UHMK1 | 0.86687621 |
| 61 | WNK1 | 0.85418804 |
| 62 | PDPK1 | 0.85271056 |
| 63 | STK11 | 0.84374407 |
| 64 | SIK2 | 0.83485760 |
| 65 | PRKCZ | 0.82521956 |
| 66 | NEK1 | 0.81260486 |
| 67 | CAMK2G | 0.78622946 |
| 68 | CAMK2A | 0.78408920 |
| 69 | MAP3K1 | 0.78236620 |
| 70 | MAP3K7 | 0.76204082 |
| 71 | MARK2 | 0.74887336 |
| 72 | RIPK4 | 0.74007585 |
| 73 | PDK1 | 0.72721086 |
| 74 | CAMK2D | 0.72581888 |
| 75 | LATS2 | 0.71525222 |
| 76 | FGFR3 | 0.70724226 |
| 77 | SGK1 | 0.69956050 |
| 78 | BCR | 0.69112071 |
| 79 | CAMK1G | 0.68866812 |
| 80 | CSNK1G2 | 0.67378097 |
| 81 | PRPF4B | 0.66937622 |
| 82 | TNK2 | 0.66543488 |
| 83 | CAMK1 | 0.62945725 |
| 84 | CAMK2B | 0.60718084 |
| 85 | RPS6KA3 | 0.60679919 |
| 86 | MAPK10 | 0.59968230 |
| 87 | PRKACG | 0.59841352 |
| 88 | MAPK13 | 0.57547631 |
| 89 | ROCK2 | 0.57380863 |
| 90 | CDK15 | 0.55824928 |
| 91 | PRKCE | 0.55487841 |
| 92 | CSNK1D | 0.54006520 |
| 93 | CDK18 | 0.53707861 |
| 94 | ALK | 0.52757736 |
| 95 | CDC42BPA | 0.52408096 |
| 96 | DYRK1B | 0.52135022 |
| 97 | ERBB2 | 0.51896429 |
| 98 | CDK14 | 0.51182054 |
| 99 | FRK | 0.50921128 |
| 100 | PRKAA1 | 0.50852571 |
| 101 | STK39 | 0.50323022 |
| 102 | MAP2K1 | 0.50167352 |
| 103 | CAMK4 | 0.49995581 |
| 104 | ICK | 0.47406909 |
| 105 | PTK6 | 0.47306081 |
| 106 | TAOK3 | 0.47261272 |
| 107 | PRKG1 | 0.46890578 |
| 108 | RPS6KB1 | 0.46669667 |
| 109 | ROCK1 | 0.46187811 |
| 110 | CSNK1G3 | 0.45789689 |
| 111 | JAK2 | 0.45668352 |
| 112 | PNCK | 0.44520382 |
| 113 | CSNK1G1 | 0.44334562 |
| 114 | PKN2 | 0.43897389 |
| 115 | PLK2 | 0.43738538 |
| 116 | CASK | 0.43355206 |
| 117 | CDK11A | 0.42988583 |
| 118 | CDK19 | 0.42588103 |
| 119 | PDK4 | 0.42341733 |
| 120 | PDK3 | 0.42341733 |
| 121 | CAMK1D | 0.42293796 |
| 122 | PDGFRA | 0.40655015 |
| 123 | SCYL2 | 0.40517389 |
| 124 | CSNK1A1L | 0.39972240 |
| 125 | PRKACA | 0.38811298 |
| 126 | CSNK1A1 | 0.38130302 |
| 127 | CSNK1E | 0.38101686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.55483578 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.37806056 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17183658 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.82718728 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.42222221 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34657181 |
| 7 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.19986687 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.12120850 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.05519926 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.02361762 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88418669 |
| 12 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.87377594 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.86026826 |
| 14 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70961934 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.68892791 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.62535368 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59032275 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56634250 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.54359420 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.52359617 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51359390 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.48653229 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44742285 |
| 24 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.42258244 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.41291451 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36963953 |
| 27 | * Propanoate metabolism_Homo sapiens_hsa00640 | 1.36531283 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27410797 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18670460 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16958245 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16171746 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14721835 |
| 33 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14170577 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10875764 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09874392 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07740329 |
| 37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.04173749 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.03762542 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01290247 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.00267372 |
| 41 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.00172419 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 0.99316928 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98535053 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 0.95320178 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95047472 |
| 46 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.93269439 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90843085 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89098927 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88797451 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85601640 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84902799 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.84739430 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84723557 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 0.84121394 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83493472 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82270553 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.82034843 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81354440 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80673737 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80098780 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78619111 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78364099 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76172578 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75980960 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75013600 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73854089 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72243879 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71466578 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69991988 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68240511 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67532427 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66423704 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66192437 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65886174 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64382470 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63889740 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63535771 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62173811 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62053618 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60792360 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59227830 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.58847678 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.58646130 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.57802034 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57486193 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56554609 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.52131512 |
| 88 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51884719 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.51149825 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48237747 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47836864 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47702551 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46932273 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45303982 |
| 95 | Phototransduction_Homo sapiens_hsa04744 | 0.45190398 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45112233 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.44265986 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43642960 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43186201 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42647305 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41725432 |
| 102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41677417 |
| 103 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40841280 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40731430 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.39716779 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39528676 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39239535 |
| 108 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38519841 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38209495 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37290925 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36911437 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36898512 |
| 113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35146858 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34422344 |
| 115 | Gap junction_Homo sapiens_hsa04540 | 0.33613095 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32709250 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30155786 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27969954 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26709694 |

